AU6847400A - Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses - Google Patents

Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses

Info

Publication number
AU6847400A
AU6847400A AU68474/00A AU6847400A AU6847400A AU 6847400 A AU6847400 A AU 6847400A AU 68474/00 A AU68474/00 A AU 68474/00A AU 6847400 A AU6847400 A AU 6847400A AU 6847400 A AU6847400 A AU 6847400A
Authority
AU
Australia
Prior art keywords
togaviridae
viruses
vitro culture
flaviviridae family
flaviviridae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68474/00A
Inventor
Patrice Andre
Florence Komurian-Pradel
Vincent Lotteau
Glaucia Paranhos-Baccala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Biomerieux SA
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Biomerieux SA
Publication of AU6847400A publication Critical patent/AU6847400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU68474/00A 1999-07-30 2000-07-31 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses Abandoned AU6847400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR99/10095 1999-07-30
FR9910095A FR2796962B1 (en) 1999-07-30 1999-07-30 METHOD FOR IN VITRO CULTURE OF VIRUSES FROM THE TOGAVIRIDAE AND FLAVIVIRIDAE FAMILIES, CELL LINE AND USES
PCT/FR2000/002202 WO2001009289A1 (en) 1999-07-30 2000-07-31 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses

Publications (1)

Publication Number Publication Date
AU6847400A true AU6847400A (en) 2001-02-19

Family

ID=9548858

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68474/00A Abandoned AU6847400A (en) 1999-07-30 2000-07-31 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses

Country Status (6)

Country Link
EP (1) EP1203076A1 (en)
JP (1) JP2003506031A (en)
AU (1) AU6847400A (en)
CA (1) CA2380407A1 (en)
FR (1) FR2796962B1 (en)
WO (1) WO2001009289A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2840921B1 (en) 2002-06-18 2008-07-18 Bio Merieux PROCESS FOR IN VITRO CULTURE OF HCV VIRUS
FR2909101B1 (en) 2006-11-24 2009-02-27 Samuel Stremsdoerfer PREFECTED NON-ELECTROLYTIC METHOD FOR METALLIZING A SUBSTRATE BY REDUCING SALT (S) OF METAL SALT (S) AND BY PROJECTING AEROSOL (S)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679342A (en) * 1987-11-18 1997-10-21 Chiron Corporation Hepatitis C virus infected cell systems
US5552310A (en) * 1992-06-12 1996-09-03 Hiroshi Yoshikura Replication of hepatitis C virus genome and identification of virus having high infectivity
WO1994025064A1 (en) * 1993-05-04 1994-11-10 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMANSERVIC ES Hepatitis c virus cell propagation and related methods
JPH10194988A (en) * 1997-01-16 1998-07-28 Sumitomo Pharmaceut Co Ltd Apoptosis suppressant

Also Published As

Publication number Publication date
EP1203076A1 (en) 2002-05-08
JP2003506031A (en) 2003-02-18
FR2796962A1 (en) 2001-02-02
CA2380407A1 (en) 2001-02-08
FR2796962B1 (en) 2003-11-21
WO2001009289A1 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
AU1939801A (en) In situ bioreactors and methods of use thereof
EP1292603B8 (en) Methods and compositions for treating hepatitis c virus
AU2001282908A1 (en) Bioreactor and bioprocessing technique
EE200100437A (en) C-21 modified epothiolones, process for their preparation and use
AU1853600A (en) Method for the detection of gene transcripts in blood and uses thereof
AU1803601A (en) Methods and compositions for the introduction of molecules into cells
HUP0200898A3 (en) Derivatives of venlafaxine and methods of preparing and using the same
AU2001245928A1 (en) Electrolyzer and method of using the same
AU2001236042A1 (en) Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2002322211A1 (en) Methods and compisitions for activation human t cells in vitro
EP1177277A4 (en) Compositions and methods for the modification of gene transcription
AU2002239740A1 (en) Nanolithography methods and products therefor and produced thereby
AU2001255767A1 (en) Methods and reagents for tissue engineering of cartilage in vitro
ZA200202816B (en) Modified plant viruses and methods of use thereof.
AU2001245288A1 (en) Overhanging form system and method of using the same
AU2001278926A1 (en) Attachments for support members and methods therefor
AU2797799A (en) (in vitro) model for viral infection and immune response
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2002346446A1 (en) Methods and compositions in checkpoint signaling
AU2001236718A1 (en) Bioreactor and related method
AU1083501A (en) Antibiotic-metal complex and methods
AU6847400A (en) Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses
EP1163340A4 (en) Compositions and methods for the modification of gene expression
AU7112700A (en) System, method, and article of manufacture for decision support in an e-commerceapplication framework

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase